T86.23, Heart transplant infectionICD-10-CM
Prior Auth Required
Conditional coverage; review criteria to confirm PA need (medium confidence)
CGS-J15-L33959, Cardiac Catheterization and Coronary Angiography
J15
CGS-J15-L34338, Transthoracic Echocardiography (TTE)
J15
CGS-J15-L34037, Flow Cytometry
J15
CGS-J15-L39038, MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
J15
Ask Backwork about documentation requirements, denial risks, or coverage in your state.
J15
CGS-J15-L38920, Off-label Use of Rituximab and Rituximab Biosimilars
J15
CGS-J18-L34338, Transthoracic Echocardiography (TTE)
J18
CGS-J18-L38920, Off-label Use of Rituximab and Rituximab Biosimilars
J18
CGS-J18-L34037, Flow Cytometry
J18
CGS-J18-L33959, Cardiac Catheterization and Coronary Angiography
J18
CGS-J18-L39038, MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
J18
CGS-J18-L33960, Cardiovascular Nuclear Medicine
J18
WPS-J5-L37205, Chemotherapy Drugs and their Adjuncts
J5
A58761, Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
J5
WPS-J5-L39044, MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
J5
A55639, Billing and Coding: Chemotherapy Agents for Non-Oncologic Conditions
J5
NGS-J6-L33557, Cardiac Catheterization and Coronary Angiography
J6
NGS-J6-L39314, Off-Label Use of Intravenous Immune Globulin (IVIG)
J6
NGS-J6-L39297, Off-label Use of Rituximab and Rituximab Biosimilars
J6
NGS-J6-L33577, Transthoracic Echocardiography (TTE)
J6